Diabetes
<ѻý class="page-description">More in Diabetes
More noteworthy research from the EASD 2024 meeting
Three-day intervention boosted time spent in normal glucose range
Relationship was mediated by comorbid dyslipidemia
Health news and commentary gathered by ѻý staff
But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use
No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials
Significant reductions in glaucoma, ocular hypertension, prescriptions versus metformin
SmartAdjust technology is used in Insulet's Omnipod 5 Automated Insulin Delivery System
Health news and commentary gathered by ѻý staff
Reports of suicidal ideation higher when compared to other drugs in WHO database
From sourcing API to getting the final formulation just right
Reactions from physician and consumer groups were positive, but drugmakers begged to differ
